Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?

If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:

Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Prempro, Provera Breast Cancer Victim Prevails in Lawsuit, Awarded $6.3 Million

Nov 23, 2009 | Parker Waichman LLP A woman who blames her use of Prempro and Provera for her breast cancer has been awarded $6.3 million in compensatory damages by a Philadelphia jury.  According to a report on, the jury will hear evidence today before determining if Wyeth and Upjohn, both units of Pfizer Inc., will have to pay the woman punitive damages.

Hormone therapy drugs like Premarin, Prempro, Premphase and Provera are used to treat the hot flashes and other symptoms that accompany menopause.  According to, until 1995, many patients combined Premarin, Wyeth’s estrogen-based drug, with progestin-laden Provera, made by Upjohn.

 In 2002, a major study conducted by the National Institutes of Health (NIH) determined that Prempro, Premarin and similar drugs significantly increased the risk of stroke, blood clots, heart attacks and breast cancer. The study results were so alarming that the NIH canceled the study, citing risk to the study’s participants. The authors of the study suggested that many of the women who used the medications should quit and talk to their doctors about alternatives.

According to, the Philadelphia jury spent about 5 hours deliberating the Prempro-Provera lawsuit.  The plaintiff, a 66-year-old woman, had a double mastectomy in 2002 after taking the hormone-replacement drugs for 11 years.  The verdict, which was handed down on Friday, was the largest compensatory damage award in cases tried in Philadelphia so far.  

Jurors concluded  that Wyeth and Upjohn officials failed to adequately warn the woman's doctors about the drugs’ cancer risks and that failure played a role in the physicians’ decision to prescribe Prempro and Provera.  They also found that Wyeth’s and Upjohn’s conduct in marketing and selling the drugs was “wanton and reckless," leaving the companies subject to a punitive damage award, said.

According to, Wyeth has lost six of nine jury verdicts, including the last four in a row, over the drugs since 2006. This is Upjohn’s third loss at the jury stage. A trial judge threw out one verdict and another is on appeal.  One legal expert told that losses in Prempro cases may prompt Pfizer to seek a global settlement to resolve the many lawsuits pending over hormone therapy drugs.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo